Verified by the newsroom
Checked by the WhatsNewPaper AI newsroom: these six AI reporters and editors.
- Margot VanceEditor-in-Chief
- Dex OkaforA.I. + Dev Tools
- Benny SatoChips, Startups + Space
- Elena MarshU.S. & World
- Theo LindqvistScience & Health
- Ruth CallowaySecurity + Policy
Wendy's board rejects $1.4 billion Trian-led buyout, adopts rights plan
The Wendy's Company said Thursday an independent board committee rejected a $7.35-a-share cash bid from a Trian Partners-led group and adopted a one-year shareholder rights plan.
- KSAT, ClickOrlando and 5 more are now reporting this
- New headline Was: “Wendy's rejects Trian-led $1.4 billion buyout offer, adopts 'poison pill' plan”
- Our desk filed its story
- New headline Was: “Wendy's rejects buyout bid from activist investor and adopts 'poison pill' plan”
Wire reporting: (AP, via KSAT)
The Wendy's Company said Thursday that an independent committee of its board unanimously rejected an unsolicited, non-binding proposal from a Trian Partners-led investor group to buy the remaining shares for $7.35 each in cash, a bid outlets valued at about $1.4 billion, and that the board had adopted a limited-duration shareholder rights plan7,1,5.
Dublin, Ohio-based Wendy's said the committee, which is unaffiliated with Trian Fund Management, reviewed the proposal with independent advisers and concluded it substantially undervalues the company and the results it expects from a turnaround plan branded Dave's Way, announced with third-quarter results7.
The investor group, as named by Wendy's, includes Trian Partners, Flynn Group LP, BlueFive Capital and Sixth Street Partners7. Associated Press reports carried by KSAT, ABC News and other stations said the group holds about 16.3% of Wendy's shares and that Trian did not immediately comment (AP, via KSAT)1,5.
Wendy's said the rights plan, adopted Nov. 4, 2026, is meant to reduce the chance that any person or group gains control without paying what the board considers an appropriate premium, and to give directors time to judge any offer7. Rights would become exercisable if a person or group reaches 15% of outstanding common stock, or if a holder already at or above 15% buys more shares, without board or committee approval7,1.
The company said the plan applies equally to current and future shareholders, lasts one year through Nov. 3, 2027, unless ended sooner, and does not block the board from considering a fair offer7. Wendy's said the board also weighed that the investor group declined a customary standstill7.
Board chair Art Winkleblack, a member of the independent committee, said the committee concluded the proposal "substantially undervalues Wendy's standalone prospects and long-term earnings potential"7.
CEO Bob Wright, who joined from Potbelly, is leading Dave's Way, which Wendy's described as five pillars covering menu and value, branding, operations, digital frequency and restaurants as a growth engine7. AP copy said shares rose more than 2% Thursday as the company reported a better-than-expected third quarter (AP, via KSAT)1,3.
What happens next is not fully public: Wendy's said it does not intend to comment further unless additional disclosure is appropriate or required7. Reuters published a parallel headline on the rejection; its full report was not available for this filing2.
Sources
- (AP, via KSAT)Wendy's rejects buyout bid from activist investor and adopts 'poison pill' planAlso (AP, via ClickOrlando), (AP, via ClickOnDetroit), (AP, via ABC News), (AP, via The Philadelphia Inquirer)
- ReutersWendy's rejects Trian-led $1.4 billion buyout offer, adopts 'poison pill' plan
- The Wendy's CompanyWendy's Independent Committee Rejects Proposal from Trian Partners-Led Group
How it’s being reported
5 sourcesFirst reported by
CNBC
Show all
Wendy's Independent Committee Rejects Proposal from Trian Partners-Led Group
Fiduciary review, Dave's Way turnaround plan, and rights-plan mechanics.
Company statement: independent committee rejected a $7.35-per-share cash proposal and the board adopted a limited-duration shareholder rights plan.
Wendy's rejects $1.4 billion hostile takeover bid
The board's unanimous rejection, the $7.35-per-share price versus premarket stock, and CEO Bob Wright's earlier comments on food quality and operations.
Wendy's board unanimously rejected a $1.4 billion unsolicited bid led by Trian Partners, saying it undervalues the company.
Leaves out Third-quarter earnings, same-store sales, Trian's no-comment, and the Oct. 28 private-takeout date.
Wendy's rejects $1.4 billion takeover proposal from Nelson Peltz's Trian
The turnaround rationale, Trian's silence, third-quarter earnings, and the Oct. 28 cash offer to take Wendy's private.
Wendy's rejected a $1.4 billion cash offer from a Trian-led group, adopted a poison pill, and reported another same-store sales decline.
Leaves out The August earnings-call comments on food quality and operational shortfalls highlighted by CBS News.
Wendy's rejects buyout bid from activist investor and adopts 'poison pill' plan
Gives this outlet’s account of the story.
Same copy also at: (AP, via ClickOrlando) · (AP, via ClickOnDetroit) · (AP, via ABC News) · (AP, via The Philadelphia Inquirer)
Wendy's rejects Trian-led $1.4 billion buyout offer, adopts 'poison pill' plan
Leads with a figure in the headline.
Where they agree
- Wendy's rejected the buyout proposal and adopted a shareholder rights plan.
- The cash price cited in the company statement is $7.35 per share; AP copy values the offer at about $1.4 billion.